Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;111(2):237-239.
doi: 10.1007/s00392-021-01974-0. Epub 2021 Nov 23.

Trends in ambulatory cardiology consultations for suspected myocarditis after COVID-19 vaccination

Holger Eggebrecht  1 , Philipp Breitbart  2 , Alexander Koch  2 , Bernd Nowak  2 , Claudia Walther  2 , Thomas Voigtländer  2 , Christoph Liebetrau  2 , Rajendra H Metha  3 , Axel Schmermund  2
Affiliations

Trends in ambulatory cardiology consultations for suspected myocarditis after COVID-19 vaccination

Holger Eggebrecht et al. Clin Res Cardiol. 2022 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Figures

Fig. 1
Fig. 1
Cumulative number of patients with suspected myopericarditis after COVID-19 vaccination. Lines depict the dates of the EMA investigation announcements
See this image and copyright information in PMC

References

    1. Verma AK, Lavine KJ, Lin C. Myocarditis after COVID-19 mRNA Vaccination. N Engl J Med. 2021 doi: 10.1056/NEJMc2109975. - DOI - PMC - PubMed
    1. Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021;144(6):471–484. doi: 10.1161/circulationaha.121.056135. - DOI - PMC - PubMed
    1. Ehrlich P, Klingel K, Ohlmann-Knafo S, Hüttinger S, Sood N, Pickuth D, Kindermann M. Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clin Res Cardiol. 2021;6:1–5. - PMC - PubMed
    1. https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-r..., Last visited: 27 Sep 2021

Substances